Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Aalto-Setälä, Katriina  [Clear All Filters]
2012
Kujala K, Ahola A, Pekkanen-Mattila M, Ikonen L, Kerkelä E, Hyttinen J, Aalto-Setälä K. Electrical Field Stimulation with a Novel Platform: Effect on Cardiomyocyte Gene Expression but not on Orientation. Int J Biomed Sci. 2012;8(2):109-120.
2013
Pradhapan P, Kuusela J, Viik J, Aalto-Setälä K, Hyttinen J. Cardiomyocyte MEA Data Analysis (CardioMDA) - A Novel Field Potential Data Analysis Software for Pluripotent Stem Cell Derived Cardiomyocytes. PLoS One. 2013;8(9):e73637.
2014
Gizatdinova Y, Rasku J, Haponen M, Joutsijoki H, Baldin I, Paci M, Hyttinen J, Aalto-Setälä K, Juhola M. Investigating local spatially-enhanced structural and textural descriptors for classification of iPSC colony images. Conf Proc IEEE Eng Med Biol Soc. 2014;2014:3361-3365.
2015
Juhola M, Penttinen K, Joutsijoki H, Varpa K, Saarikoski J, Rasku J, Siirtola H, Iltanen K, Laurikkala J, Hyyrö H, et al. Signal analysis and classification methods for the calcium transient data of stem cell-derived cardiomyocytes. Comput Biol Med. 2015;61:1-7.
Paavola J, Väänänen H, Larsson K, Penttinen K, Toivonen L, Kontula K, Laine M, Aalto-Setälä K, Swan H, Viitasalo M. Slowed depolarization and irregular repolarization in catecholaminergic polymorphic ventricular tachycardia: a study from cellular Ca2+ transients and action potentials to clinical monophasic action potentials and electrocardiography. Europace. 2015.
2020
Joutsijoki H, Penttinen K, Juhola M, Aalto-Setälä K. Separation of HCM and LQT Cardiac Diseases with Machine Learning of Ca2+ Transient Profiles. Methods Inf Med. 2020.
2021
Juhola M, Joutsijoki H, Penttinen K, Shah D, Aalto-Setälä K. On computational classification of genetic cardiac diseases applying iPSC cardiomyocytes. Comput Methods Programs Biomed. 2021;210:106367.
Prajapati C, Ojala M, Lappi H, Aalto-Setälä K, Pekkanen-Mattila M. Electrophysiological evaluation of human induced pluripotent stem cell-derived cardiomyocytes obtained by different methods. Stem Cell Res. 2021;51:102176.
2023
Alexanova A, Raitoharju E, Valtonen J, Aalto-Setälä K, Viiri LE. Coronary artery disease patient-derived iPSC-hepatocytes have distinct miRNA profile that may alter lipid metabolism. Sci Rep. 2023;13(1):1706.
Penttinen K, Prajapati C, Shah D, Rajan DKattippara, Cherian RMaria, Swan H, Aalto-Setälä K. HiPSC-derived cardiomyocyte to model Brugada syndrome: both asymptomatic and symptomatic mutation carriers reveal increased arrhythmogenicity. BMC Cardiovasc Disord. 2023;23(1):208.
Suominen S, Hyypijev T, Venäläinen M, Yrjänäinen A, Vuorenpää H, Lehti-Polojärvi M, Räsänen M, Seppanen A, Hyttinen J, Miettinen S, et al. Improvements in Maturity and Stability of 3D iPSC-Derived Hepatocyte-like Cell Cultures. Cells. 2023;12(19).